Dr. Martin E Gutierrez
Claim this profileJohn Theurer Cancer Center at Hackensack University Medical Center
Expert in Lung Cancer
Expert in Solid Tumors
48 reported clinical trials
85 drugs studied
About Martin E Gutierrez
Education:
- Obtained MD from the University of Texas Southwestern Medical School, Dallas, TX.
Experience:
- Completed Residency in Internal Medicine at the University of Texas Southwestern Medical Center, Dallas, TX.
- Undertook Fellowship in Hematology and Oncology at the same institution.
- Serving as an attending physician at the John Theurer Cancer Center at Hackensack University Medical Center, with a specialization in hematology and oncology.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Martin E Gutierrez is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This clinical trial plans to assess to what extent the on-treatment circulating tumor DNA (ctDNA) can predict the subset of patients with NSCLC who will respond to immunotherapy treatment only and which patients will need both immunotherapy and chemotherapy modalities for their treatment regimen.
Recruiting1 award Phase 219 criteria
Atezolizumab + Bevacizumab
for Gastrointestinal Cancer
This study is a non-randomized, open-label, multi-cohort, multi-site, pilot feasibility therapeutic trial. The study will enroll 20 patients across 4 cohorts (CRC, gastric, PDAC, and HCC/intra-hepatic-/extra-hepatic-, gall bladder adenocarcinomas) diagnosed with histologically confirmed GI cancers. These patients will have already completed all Standard of Care (SOC) treatments (including neoadjuvant, surgery, local therapies, and/or adjuvant therapy as applicable), as defined by the treating primary physician or research team, with curative intent but have a positive SignateraTM tumor-informed ctDNA test and NED radiographically by standard imaging within 28 days prior to enrollment and within 1 year of completing all curative-intent therapy. All patients will be treated with intravenous (IV) atezolizumab 1200 mg IV and bevacizumab 15 mg/kg on Day 1 of 21-day cycles until disease recurrence, ctDNA POD, unacceptable toxicity, or subject withdrawal of consent with a maximum 12 month total duration of study therapy. Atezolizumab and bevacizumab drug will be provided.
Recruiting2 awards Phase 3
More about Martin E Gutierrez
Clinical Trial Related3 years of experience running clinical trials · Led 48 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Martin E Gutierrez has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Carboplatin
- Docetaxel
- Atezolizumab
Breakdown of trials Martin E Gutierrez has run
Lung Cancer
Solid Tumors
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martin E Gutierrez specialize in?
Martin E Gutierrez focuses on Lung Cancer and Solid Tumors. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Martin E Gutierrez currently recruiting for clinical trials?
Yes, Martin E Gutierrez is currently recruiting for 14 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Martin E Gutierrez has studied deeply?
Yes, Martin E Gutierrez has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Martin E Gutierrez?
Apply for one of the trials that Martin E Gutierrez is conducting.
What is the office address of Martin E Gutierrez?
The office of Martin E Gutierrez is located at: John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the John Theurer Cancer Center at Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.